Philip Ward

Philip Ward is ACT's European editor, fax +44 (1244) 533933, ward@deeside.demon.co.uk

A major European congress looks set to focus attention on the growing campaign for more participation of the elderly in clinical trials.

The ICH GCP guideline continues to age and while members of the Institute of Clinical Research voice the need for its revision, industry debates whether changes are necessary.

Indian CROs face new guidelines as the country's clinical trial market continues to face infrastructure issues.

Vital players come together in an attempt to find a cure for a devastating illness predominantly effecting African countries.

The current state of the clinical trial market in Russia.

The European intiative of involving elderly in clinical trials picks up the pace as challenges are addressed.

Industry professionals address critical commentary of the drug development process.

Regulatory authorities in Italy enforce new legislation that hardens the requirements for education and certification of staff at CROs.

The Netherlands has become the latest European country to establish a network that is designed to promote pediatric drug development.